Senator Sheldon Whitehouse will join leaders of Rhode Island's biotechnology community for a tour of EpiVax’s new facilities before participating in a Q&A session.
The group will discuss prospects for, and impediments to, the continued growth of this important Rhode Island industry.1 The Senator also will discuss how federal health care policy and budget debates could impact biomedical innovation.
|
WHAT: |
Tour and Q&A at EpiVax | |
|
WHO: |
Senator Sheldon Whitehouse | |
| Christine Smith, RI Commerce Corporation | ||
| Annie De Groot, Founder, CEO & CSO, EpiVax | ||
| Jim Greenwood, President and CEO, BIO | ||
|
Other members of Rhode Island bioscience community |
||
|
WHEN: |
Friday, June 15, 2018, at 5:30pm | |
|
WHERE: |
EpiVax, Inc. (Rising Sun Mill Bldg.) | |
| 188 Valley Street | ||
| Providence, RI | ||
Media requested to RSVP to George Goodno, mailto:ggoodno@bio.org
About BIO
BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIOtechNOW is BIO's blog chronicling “innovations transforming our world” and the BIO Newsletter is the organization’s bi-weekly email newsletter. Subscribe to the BIO Newsletter.
View source version on businesswire.com:
BIO
George Goodno, 202-962-6660